Literature DB >> 1775152

Biochemical and molecular characterization of Leishmania pifanoi amastigotes in continuous axenic culture.

P M Rainey1, T W Spithill, D McMahon-Pratt, A A Pan.   

Abstract

Inability to culture the disease-producing amastigote form of Leishmania has greatly hampered its study. We have biochemically characterized an axenically cultured amastigote-like form of Leishmania pifanoi. This form closely resembles amastigotes in proteinase, ribonuclease, adenine deaminase and peroxidase activity. It also exhibits comparable rates of growth, transformation, synthesis of DNA, RNA and protein, and metabolism of glucose and linoleic acid. It is distinct from promastigotes in these characteristics. The expression of the genes for beta-tubulin and the P100/11E reductase is developmentally regulated in this axenic form as in amastigotes. These results, combined with previous demonstrations of amastigote morphology and antigenicity in the culture form, confirm that Leishmania amastigotes have been successfully propagated in axenic media. This strain should serve as an excellent model for the study of amastigote biochemistry, pharmacology and immunology, and the molecular genetics of the transformation between amastigote and promastigote forms.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1775152     DOI: 10.1016/0166-6851(91)90134-r

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  11 in total

1.  An axenic amastigote system for drug screening.

Authors:  H L Callahan; A C Portal; R Devereaux; M Grogl
Journal:  Antimicrob Agents Chemother       Date:  1997-04       Impact factor: 5.191

2.  In vitro life cycle of pentamidine-resistant amastigotes: stability of the chemoresistant phenotypes is dependent on the level of resistance induced.

Authors:  D Sereno; J L Lemesre
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

3.  Flavonoid dimers as bivalent modulators for pentamidine and sodium stiboglucanate resistance in leishmania.

Authors:  Iris L K Wong; Kin-Fai Chan; Brendan A Burkett; Yunzhe Zhao; Yi Chai; Hongzhe Sun; Tak Hang Chan; Larry M C Chow
Journal:  Antimicrob Agents Chemother       Date:  2006-12-28       Impact factor: 5.191

4.  Axenically cultured amastigote forms as an in vitro model for investigation of antileishmanial agents.

Authors:  D Sereno; J L Lemesre
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

5.  Leishmania pifanoi amastigote antigens protect mice against cutaneous leishmaniasis.

Authors:  L Soong; S M Duboise; P Kima; D McMahon-Pratt
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

6.  Antileishmanial activity of sodium stibogluconate fractions.

Authors:  W L Roberts; P M Rainey
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

7.  RNA editing and mitochondrial activity in promastigotes and amastigotes of Leishmania donovani.

Authors:  Martina Nebohácová; Christine E Kim; Larry Simpson; Dmitri A Maslov
Journal:  Int J Parasitol       Date:  2008-12-10       Impact factor: 3.981

8.  A radioiodinated peptidyl diazomethane detects similar cysteine proteinases in amastigotes and promastigotes of Leishmania (L.) mexicana and L. (L.) amazonensis.

Authors:  S C Alfieri; J M Balanco; E M Pral
Journal:  Parasitol Res       Date:  1995       Impact factor: 2.289

9.  Developmental changes in the expression of Leishmania chagasi gp63 and heat shock protein in a human macrophage cell line.

Authors:  J A Streit; J E Donelson; M W Agey; M E Wilson
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

10.  Translational control through eIF2alpha phosphorylation during the Leishmania differentiation process.

Authors:  Serge Cloutier; Maxime Laverdière; Marie-Noelle Chou; Nathalie Boilard; Conan Chow; Barbara Papadopoulou
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.